• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Blogs » The Carlat Psychiatry Blog » Top 15 Carlat Psychiatry Articles of 2023

The Carlat Psychiatry Blog
The Carlat Psychiatry Blog RSS FeedRSS

Top 15 Carlat Psychiatry Articles of 2023

December 29, 2023
CarlatThumb.png

YEAR IN REVIEW

These are the most-read articles from the past year. They are free to read even if you don't have Total Access to the Carlat archives. Scroll through them to get to the top article of the year.


#15 Which SSRI Is Best for Panic Disorder?
By Rushaniya Khairova, MD, PhD.

Guidelines recommend SSRIs first line, but it’s not clear how these options compare in efficacy and tolerability. This network meta-analysis aimed to address that.
 
Read the article »


#14 What to Know About Injectable Buprenorphine (Sublocade)
By Audrey Abelleira, PharmD, BCPP

Long-acting formulations of sublocade have been developed to enhance adherence, with a subcutaneous injectable called ­Sublocade leading the pack. Let’s take a closer look.
 
Read the article »


#13 Is It Worth Adding Coenzyme Q10 to Atomoxetine for ADHD?

By Dorothy Chyung, MD

In this study, researchers tested whether augmentation of atomoxetine with the antioxidant coenzyme Q10 would further improve ADHD symptoms.
 
Read the article »



#12 Interpreting Urine Drug Tests
With Karen Moeller, PharmD

How reliable are urine tests? Reliability depends on the type of drug test. Immunoassays are commonly the first method of testing because they are fast and inexpensive, but their specificity is low, so they can produce false positives.
 
Read the Expert Q&A »



#11 Treating Irritability in Autistic Children: Functional and Medication Approaches
By Joshua Feder, MD

Don’t be the prescriber who hears irritability in autism and immediately prescribes antipsychotics. There are usually multiple steps to try before using the FDA-approved antipsychotic medications.
 
Read the article »
Listen to the podcast episode »



#10 Zuranolone: 10 Questions about a New Antidepressant
By Chris Aiken, MD

Zuranolone (Zurzuvae) is newly approved for postpartum depression, but does it work in regular depression? And why did they put so many “Zs” in the name?

 Listen to the podcast episode »


#9 Recognizing and Treating Psychosis in Autism
With Kristin Cadenhead, MD

How often does psychosis co-occur with autism? It’s more often than the 1% in the general population.

 Read the Expert Q&A »


#8 SSRIs and Hydroxyzine for Avoidant/Restrictive Food Intake Disorder (ARFID)?
By Joshua Feder, MD

Clinicians use olanzapine, mirtazapine, and other appetite-inducing medications off label to treat ARFID, but with little research to support their use. This study unpacks the potential role of medications in treating comorbid symptoms associated with ARFID.

 Read the article »


#7 Dissociative Identity Disorder vs Plural Identity in Teens and Young Adults
With Paroma Mitra, MD

The DSM-5 diagnostic criteria for DID includes two or more distinct personalities, each with the sense of consciousness and memory.

 Read the Expert Q&A »


#6 Mania in Older Adults
By Julia Cromwell, MD


Although less common, a first episode of mania can present in late life. Older patients will often present with standard manic symptoms.

Read the article »


#5 Mood Stabilizers for Bipolar Disorder in Older Adults: Special Considerations
By Rehan Aziz, MD

Bipolar disorder (BD) is one of the most challenging illnesses to treat in psychiatry, especially bipolar depression. In older adults, changes in metabolism and medical comorbidities can result in a higher risk of side effects with first-line agents.

 Read the article »

#4 Auvelity: A Fast-Acting Antidepressant?
By Chris Aiken, MD

Auvelity is a combination of two older medications: bupropion (circa 1985) and dextromethorphan (circa 1958), a cough suppressant found in Robitussin DM.

Read the article »


#3 Stimulant Dosing Limits
By Chris Aiken, MD and Kelvin Quiñones-Laracuente, MD, PhD

Stimulant dosing presents a unique challenge. These medications are inherently rewarding, which means we can’t take a purely collaborative approach and let patients guide the dose.

 Read the article »

#2 Deprescribing Anti-anxiety Medications in Older Adults
By Rachel Meyen, MD


Our inclination may be to “not rock the boat” when a patient is stable and not misusing prescribed medication. However, tapering anti-anxiety medications in older adults is often a good idea when considering the risks of falls, sedation, and accidents.

Read the article »

#1 Viibryd Goes Generic, But Is It Worth Prescribing?

By Chris Aiken, MD

After 11 years of market exclusivity, vilazodone (Viibryd) lost its patent in June of 2022. The price of this “multimodal” antidepressant has fallen to $40 a month and may fall further as more manufacturers enter the market. More patients can afford to take it, but whether we should prescribe more vilazodone is less clear. 

Read the article »


Need CME? Carlat has you covered.

Choose the CME subscription that's best for you to get instant access to up to 80 CME credits.


Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.